Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • Clinical Compendia
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • Clinical Compendia
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Departments

Ensuring Our Future

  1. Stephen A. Brunton, Editor-in-Chief
  1. Primary Care Metabolic Group, Los Angeles, CA
  1. Corresponding author: Stephen A. Brunton, sbrunton{at}pceconsortium.com
Clinical Diabetes 2018 Jul; 36(3): 216-216. https://doi.org/10.2337/cd18-0035
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

The pandemic of diabetes is accelerating at an alarming rate; however, my concern is that the education of future clinicians is not keeping up. Although resident physicians are managing patients with diabetes in both inpatient and outpatient environments, their prior formal education has been limited. There is minimal or no exposure to the breadth of therapeutic options as outlined in guidelines from the American Diabetes Association and the American Association of Clinical Endocrinologists. There is minimal knowledge and experience with newer drug classes such as dipeptidyl peptidase 4 inhibitors, glucagon-like peptide 1 receptor agonists, and sodium–glucose cotransporter 2 inhibitors. Metformin and sulfonylureas are the basis of therapy in many of these residency programs, and the complexities of insulin management remain challenging to many. This situation deprives our patients of medical advances and current thinking.

One effort to address this issue is an annual conference on contemporary diabetes management that is convened by the Primary Care Education Consortium for chief residents in family medicine. Through this conference, now in its 12th year, 65 third-year residents from around the United States gather for a weekend of comprehensive education. The experience starts on a Friday with the application of an insulin pump (loaded with saline) and a continuous glucose monitoring system for each resident and continues with lectures and workshops throughout the weekend. Each meal served during the conference comes with nutrition information with which the residents are supposed to calculate their appropriate “insulin” dose.

The impact of this experience is profound! After their intensive educational experience, these physicians exhibit dramatic changes in knowledge, attitudes, and skills and experience renewed enthusiasm and greater confidence in partnering with their patients to optimize the management of diabetes.

But what about other trainees who do not have the opportunity to participate in this conference? What is their exposure to state-of-the-art diabetes care? With limited formularies in most teaching hospitals, even endocrine fellowship programs are not able to provide their fellows with adequate exposure to and experience with newer therapies.

If we are to address the current needs of people with diabetes, let alone the growing numbers in the future, there is an urgent need to improve and expand the education of medical students and residents. This needs to be a priority. Our patients’ futures are at stake.

Duality of Interest

The author is Executive Vice President of the Primary Care Education Consortium. No other potential conflicts of interest relevant to this article were reported.

  • © 2018 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.

PreviousNext
Back to top
Clinical Diabetes: 36 (3)

In this Issue

July 2018, 36(3)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Clinical Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ensuring Our Future
(Your Name) has forwarded a page to you from Clinical Diabetes
(Your Name) thought you would like to see this page from the Clinical Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Ensuring Our Future
Stephen A. Brunton
Clinical Diabetes Jul 2018, 36 (3) 216; DOI: 10.2337/cd18-0035

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Ensuring Our Future
Stephen A. Brunton
Clinical Diabetes Jul 2018, 36 (3) 216; DOI: 10.2337/cd18-0035
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Duality of Interest
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Departments

  • Transitioning to Fixed-Ratio Combination Therapy: Five Frequently Asked Questions Health Care Providers Should Anticipate From Their Patients
  • Gvoke HypoPen: An Auto-Injector Containing an Innovative, Liquid-Stable Glucagon Formulation for Use in Severe Acute Hypoglycemia
  • Timely News and Notes for Primary Care Providers from the American Diabetes Association
Show more Departments

Editorial

  • I Am Not a “Provider”
  • Telemedicine: The 2020 House Call
  • Black Diabetic Lives Matter
Show more Editorial

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Abridged Standards of Care
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.